Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
RESEARCH TOOLSreports
Holding DERM?
Track your performance easily
DERM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.92 - $8.11
Previous Close$4.98
Volume49.04K
Average Volume (3M)77.92K
Market Cap
$107.99M
Enterprise Value$103.88M
Total Cash (Recent Filing)$23.91M
Total Debt (Recent Filing)$19.81M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Nov 06, 2024EPS Estimate
-$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding20,727,237
10 Day Avg. Volume50,168
30 Day Avg. Volume77,925
Standard Deviation0.20
R-Squared0.06
Alpha0.00157
Financial Highlights & Ratios
Price to Book (P/B)-14.67
Price to Sales (P/S)1.39
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.34
Enterprise Value/Gross Profit1.98
Enterprise Value/Ebitda19.33
Forecast
1Y Price Target
$9.33Price Target Upside87.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Journey Medical Corp News
PremiumCompany Announcements
Journey Medical Expands Loan Facility and Strengthens Leadership
Ownership Overview
76.06% Insiders
2.62% Mutual Funds
7.27% Other Institutional Investors
14.06% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DERM FAQ
What was Journey Medical Corp’s price range in the past 12 months?
Journey Medical Corp lowest stock price was $1.92 and its highest was $8.11 in the past 12 months.
What is Journey Medical Corp’s market cap?
Currently, no data Available
When is Journey Medical Corp’s upcoming earnings report date?
Journey Medical Corp’s upcoming earnings report date is Nov 06, 2024 which is in 67 days.
How were Journey Medical Corp’s earnings last quarter?
Journey Medical Corp released its earnings results on Aug 12, 2024. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.143 by -$0.027.
Is Journey Medical Corp overvalued?
According to Wall Street analysts Journey Medical Corp’s price is currently Undervalued.
Does Journey Medical Corp pay dividends?
Journey Medical Corp does not currently pay dividends.
What is Journey Medical Corp’s EPS estimate?
Journey Medical Corp’s EPS estimate is -$0.17.
How many shares outstanding does Journey Medical Corp have?
Journey Medical Corp has 14,727,237 shares outstanding.
What happened to Journey Medical Corp’s price movement after its last earnings report?
Journey Medical Corp reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.143. Following the earnings report the stock price went up 14.218%.
Which hedge fund is a major shareholder of Journey Medical Corp?
Among the largest hedge funds holding Journey Medical Corp’s share is Royce & Associates LLC. It holds Journey Medical Corp’s shares valued at 71K.
---
Journey Medical Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.33 (87.35% Upside)
$9.33 (87.35% Upside)
Blogger Sentiment
Bullish
DERM Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $72.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
139.42%
12-Months-Change
Fundamentals
Return on Equity
14.92%
Trailing 12-Months
Asset Growth
-6.54%
Trailing 12-Months
Company Description
Journey Medical Corp
Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
---
DERM Earnings Call
Q2 2024
0:00 / 0:00
---
DERM Stock 12 Month Forecast
Average Price Target
$9.33
▲(87.35% Upside)
Technical Analysis
Aileron Therapeutics
―
Beam Therapeutics
―
Fate Therapeutics
―
Helius Medical Technologies
―
Best Analysts Covering DERM
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+25.44%
initiated a buy rating 7 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +25.44% per trade.
---